USPTO Examiner SEVERSON RYAN J - Art Unit 3771

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19180391SELF-LOCKING TOURNIQUETApril 2025December 2025Allow800NoNo
19058548COMPRESSION GARMENT FOR WINDING AND APPLYING ON LEG, ARM OR UPPER LIMBFebruary 2025April 2025Allow200NoNo
18878081Styptic harness tourniquetDecember 2024May 2025Allow510NoNo
18934919INSTRUMENT FOR SURGERYNovember 2024December 2024Allow200NoNo
18895980Methods for Postpartum Uterine HemostasisSeptember 2024February 2026Allow1600NoNo
18826015Step Needle for Intraosseous Access DeviceSeptember 2024February 2026Allow1800NoNo
18807575THROMBECTOMY DEVICES WITH LATERAL AND VERTICAL BIASAugust 2024November 2024Allow300NoNo
18780833SURGICAL INSTRUMENTS FOR ANTERIOR GONIOTOMYJuly 2024November 2024Allow400NoNo
18780153Windlass TourniquetJuly 2024October 2025Allow1500YesNo
18773785FORCEPS DEVICEJuly 2024March 2026Allow2000NoNo
18767070PET INTRAURETHRAL INCISION KNIFEJuly 2024October 2024Allow300NoNo
18726258OCCLUSION DEVICES AND METHODS OF USE THEREOFJuly 2024January 2026Allow1800NoNo
18760807OPHTHALMIC SURGERY INSTRUMENT, INTRAOCULAR EXCISION MEMBER, AND MANUFACTURING METHOD THEREFORJuly 2024December 2025Allow1800NoNo
18724267Occluder and Occluding SystemJune 2024October 2025Allow1600NoNo
18753572EXTENDIBLE AND RETRACTABLE ENDOSCOPIC CAPJune 2024January 2026Allow1900NoNo
18680836SURGICAL CLIPMay 2024June 2025Allow1210NoNo
18678689HEMOSTASIS CLIP TWO STAGE DEPLOYMENT MECHANISM TO ELIMINATE SHED PARTSMay 2024June 2025Allow1310NoNo
18677410HEMOSTASIS CLIPMay 2024November 2025Allow1710NoNo
18672710REPOSITIONABLE CLIP WITH SYMMETRIC OPEN FORCEMay 2024October 2025Allow1600NoNo
18667760SURGICAL CLIP APPLIERMay 2024October 2025Allow1710NoNo
18665973Steerable Endoluminal Punch with Introducer and GuidewireMay 2024October 2025Allow1710NoNo
18656580NATURAL FIBERS HAVING ABSORBABLE AND HYDROPHOBIC PROPERTIES FOR MAKING SURGICAL SUTURES AND SURGICAL MESHESMay 2024November 2024Allow701NoNo
18651733Carpal Tunnel Release Systems and MethodsMay 2024July 2025Allow1510NoNo
18651061INSTRUMENT FOR SURGERYApril 2024January 2025Allow900NoNo
18645606ENDOVASCULAR DEVICE WITH A TISSUE PIERCING DISTAL PROBE AND ASSOCIATED METHODSApril 2024October 2025Allow1700NoNo
18643007TETHER TRACTION SYSTEMS AND METHODS OF USE THEREOFApril 2024May 2025Allow1310YesNo
18641746DERMAL REJUVENATION SYSTEMApril 2024December 2024Allow820NoNo
18637133SURGICAL INSTRUMENTS FOR ANTERIOR GONIOTOMYApril 2024August 2024Allow410NoNo
18632411TISSUE GRAFTS WITH PRE-MADE ATTACHMENT POINTSApril 2024October 2025Allow1810NoNo
18694708DOUBLE-BALLOON CATHETERMarch 2024October 2025Allow1900NoNo
18612814ATRIAL CLIP ASSEMBLY AND DELIVERY DEVICEMarch 2024December 2025Allow2100NoNo
18604060HEMOSTATIC CLIP WITH NEEDLE PASSERMarch 2024April 2025Allow1310NoNo
18595154DIRECTIONAL ENHANCEMENT FEATURE FOR ARTICULATION CATHETERMarch 2024June 2025Allow1510NoNo
18594295ENDOSCOPIC TREATMENT DEVICEMarch 2024December 2024Allow1000NoNo
18590705EMBOLIC PROTECTION DEVICE AND METHODFebruary 2024July 2025Allow1710YesNo
18587911DIRECTED FLUIDICSFebruary 2024January 2025Allow1110NoNo
18584984OBSTRUCTION REMOVAL SYSTEMFebruary 2024February 2025Allow1210NoNo
18582897MECHANICALLY EXPANDING HEART VALVE AND DELIVERY APPARATUS THEREFORFebruary 2024February 2025Allow1210NoNo
18444173Surgical Instrument and Method for Occlusion of Uterine Blood VesselsFebruary 2024June 2024Allow400YesNo
18440052GRAFT PREPARATION SYSTEMFebruary 2024July 2025Allow1710NoNo
18433952ATHERECTOMY DEVICES AND METHODSFebruary 2024October 2024Allow800NoNo
18433170INTRAVASCULAR TREATMENT OF VASCULAR OCCLUSION AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSFebruary 2024April 2025Allow1411NoNo
18428049RIGGERS BELT WITH INTEGRATED MEDICAL TOURNIQUETJanuary 2024October 2025Allow2000NoNo
18424403INTERNAL ILIAC PRESERVATION DEVICES AND METHODSJanuary 2024July 2025Allow1710NoNo
18410718CLIP DEPLOYMENT TOOL AND ASSOCIATED METHODSJanuary 2024January 2025Allow1210NoNo
18406951HEMOSTASIS CLIP DEPLOYMENTJanuary 2024October 2024Allow910NoNo
18404402ROBOTIC SURGICAL INSTRUMENTJanuary 2024October 2024Allow900YesNo
18401609INSTRUMENT FOR SURGERYDecember 2023December 2024Allow1110NoNo
18401628INSTRUMENT FOR SURGERYDecember 2023December 2024Allow1110NoNo
18399012Garment Torniquet DeviceDecember 2023September 2025Allow2100NoNo
18395572METHOD AND CATHETER FOR CREATING AN INTERATRIAL APERTUREDecember 2023October 2025Allow2120NoNo
18535982Steerable Endoluminal Punch With Cutting StyletDecember 2023February 2025Allow1410NoNo
18533319VASCULAR PROSTHESIS FOR LEAK PREVENTION DURING ENDOVASCULAR ANEURYSM REPAIRDecember 2023November 2024Allow1110NoNo
18531032SURGICAL THREADDecember 2023June 2025Allow1900NoNo
18522592SURGICAL CLIP AND DEPLOYMENT SYSTEMNovember 2023February 2025Allow1410NoNo
18519038APPARATUS AND METHODS FOR CLOSING VESSELSNovember 2023September 2025Allow2100NoNo
18517482BALLOON EXPANDABLE ENDOPROSTHESISNovember 2023October 2024Allow1110NoNo
18508343Uterine Toner Device with Balloon to Prevent and Control Postpartum HemorrhageNovember 2023August 2024Allow910NoNo
18505460Medical Device for a Cardiac Valve ImplantNovember 2023March 2025Allow1700YesNo
18504498ENDOSCOPIC SURGICAL CLIP APPLIERNovember 2023January 2025Allow1510NoNo
18500359ENHANCED TECHNIQUES FOR INSERTION AND EXTRACTION OF A BOUGIE DURING GASTROPLASTYNovember 2023December 2024Allow1310NoNo
18500571Systems, Devices, and Methods for Uterine HemostasisNovember 2023October 2025Allow2310NoNo
18498314FLEXIBLE MEMBER FOR ANGLED SYSTEMOctober 2023June 2025Allow1910NoNo
18499079OCULAR IMPLANT WITH STIFFNESS QUALITIES, METHODS OF IMPLANTATION AND SYSTEMOctober 2023October 2024Allow1210NoNo
18496608REAR-END TRANSMISSION DEVICE, SURGICAL INSTRUMENT, AND SURGICAL ROBOTOctober 2023June 2025Allow2000NoNo
18380926ATHERECTOMY DEVICES AND METHODSOctober 2023January 2025Allow1510NoNo
18379748SURGICAL DEVICES AND METHODSOctober 2023August 2024Allow1110NoNo
18379457IMPLANTABLE MEDICAL DEVICE CONSTRAINT AND DEPLOYMENT APPARATUSOctober 2023February 2025Allow1610NoNo
18379352METHOD FOR CLOSING WOUNDOctober 2023September 2024Allow1110NoNo
18483192FRICTION COMPENSATING, EVEN PRESSURE CLIPOctober 2023October 2025Allow2400NoNo
18479471SUTURE ANCHOR CONSTRUCTOctober 2023May 2024Allow800NoNo
18476758TRANSSEPTAL SYSTEMS AND METHODSSeptember 2023July 2025Allow2110NoNo
18476268SURGICAL KNIFE SAFETY HANDLE HAVING USER OPERABLE LOCKSeptember 2023August 2024Allow1110NoNo
18552425ENDOSCOPIC TREATMENT TOOLSeptember 2023August 2025Allow2200YesNo
18470324INTRAOCULAR LENS STORAGE AND LOADING DEVICES AND METHODS OF USESeptember 2023October 2024Allow1310NoNo
18467557AGGRESSIVE FEATURED CLIPS WITH IMPROVED TISSUE RETENTIONSeptember 2023July 2024Allow1010NoNo
18465564ROBOTIC SURGICAL ASSEMBLIESSeptember 2023August 2024Allow1210NoNo
18242555TOURNIQUET CLIPSeptember 2023November 2024Abandon1410NoNo
18452385SYSTEMS AND METHODS FOR ENTRY POINT LOCALIZATIONAugust 2023August 2024Allow1210NoNo
18233727Emergency Protocol Receptacle for Puncture WoundsAugust 2023September 2025Allow2500NoNo
18231141SMALL GAUGE SURGICAL INSTRUMENT WITH SUPPORT DEVICEAugust 2023August 2024Allow1210NoNo
18363814Tissue Grasping Devices And Related MethodsAugust 2023July 2024Allow1110NoNo
18363300DUAL EXPANSION ANCHORAugust 2023September 2024Allow1310NoNo
18221443ULTRASONIC SURGICAL SHEARS AND METHOD FOR SEALING A BLOOD VESSEL USING SAMEJuly 2023December 2024Allow1710NoNo
18351307INTRAVASCULAR TREATMENT OF VASCULAR OCCLUSION AND ASSOCIATED DEVICES, SYSTEMS, AND METHODSJuly 2023January 2024Allow610NoNo
18350766CLIP DEVICES, CLIP APPARATUSES, AND METHODS FOR UNLOCKING OF CLIP DEVICESJuly 2023June 2025Allow2300NoNo
18340926CLIP APPLYING MECHANISM AND CLIP APPLYING APPARATUS THEREOFJune 2023October 2025Allow2700NoNo
18339673CARTRIDGE SYSTEM, CARTRIDGE, AND LOADING METHOD OF CLIP UNITJune 2023September 2025Allow2700NoNo
18338433GASTRIC REDUCTION APPARATUS AND RELATED METHODSJune 2023February 2024Allow800YesNo
18338116SYSTEMS AND METHODS FOR SURGICAL PROCEDURES USING TORQUE DRIVEN GUIDE WIREJune 2023October 2024Allow1610NoNo
18324930SUTURE CLIP DEPLOYMENT DEVICEMay 2023March 2024Allow1010NoNo
18199912LINEAR TISSUE CLIPPING DEVICEMay 2023April 2025Allow2300NoNo
18316557Uterine Toner Device to Prevent and Control Postpartum HemorrhageMay 2023September 2023Allow400NoNo
18196979SURGICAL CLIPMay 2023January 2024Allow800NoNo
18196228PROXIMAL LOCKING ASSEMBLY DESIGN FOR DUAL STENT MECHANICAL THROMBECTOMY DEVICEMay 2023February 2024Allow900NoNo
18296026OPTIMIZED PNEUMATIC DRIVE LINESApril 2023April 2025Allow2411NoNo
18127243LAPAROSCOPE FOR INSTALLING SURGICAL CLIPSMarch 2023June 2023Allow300NoNo
18190568SURGICAL CLIP APPLIER WITH PARALLEL CLOSURE JAWSMarch 2023June 2024Abandon1510NoNo
18185928ENDOLUMINAL PROSTHESIS HAVING MULTIPLE BRANCHES OR FENESTRATIONS AND METHODS OF DEPLOYMENTMarch 2023July 2024Allow1620YesNo
18121606BILATERAL REVERSIBLE VENOUS TOURNIQUET BANDSMarch 2023May 2025Allow2600NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner SEVERSON, RYAN J.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
8
Examiner Affirmed
4
(50.0%)
Examiner Reversed
4
(50.0%)
Reversal Percentile
79.1%
Higher than average

What This Means

With a 50.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is in the top 25% across the USPTO, indicating that appeals are more successful here than in most other areas.

Strategic Value of Filing an Appeal

Total Appeal Filings
17
Allowed After Appeal Filing
6
(35.3%)
Not Allowed After Appeal Filing
11
(64.7%)
Filing Benefit Percentile
58.3%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 35.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is above the USPTO average, suggesting that filing an appeal can be an effective strategy for prompting reconsideration.

Strategic Recommendations

Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner SEVERSON, RYAN J - Prosecution Strategy Guide

Executive Summary

Examiner SEVERSON, RYAN J works in Art Unit 3771 and has examined 452 patent applications in our dataset. With an allowance rate of 92.9%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 28 months.

Allowance Patterns

Examiner SEVERSON, RYAN J's allowance rate of 92.9% places them in the 79% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by SEVERSON, RYAN J receive 1.43 office actions before reaching final disposition. This places the examiner in the 23% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by SEVERSON, RYAN J is 28 months. This places the examiner in the 71% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +4.6% benefit to allowance rate for applications examined by SEVERSON, RYAN J. This interview benefit is in the 29% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 33.5% of applications are subsequently allowed. This success rate is in the 73% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 50.8% of cases where such amendments are filed. This entry rate is in the 77% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 44.4% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 41% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 52% percentile among all examiners. Of these withdrawals, 18.8% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 50.8% are granted (fully or in part). This grant rate is in the 50% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 1.8% of allowed cases (in the 73% percentile). This examiner makes examiner's amendments more often than average to place applications in condition for allowance (MPEP § 1302.04).

Quayle Actions: This examiner issues Ex Parte Quayle actions in 10.5% of allowed cases (in the 89% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.